Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
AstraZeneca
University of Nebraska
Inhibrx Biosciences, Inc
Petrov, Andrey
Nanobiotix
University of Colorado, Denver
Travera Inc
Thomas Jefferson University
Columbia University
Travera Inc
Celldex Therapeutics
Klus Pharma Inc.
Eastern Cooperative Oncology Group
National Institutes of Health Clinical Center (CC)
Osaka University
University of Wisconsin, Madison
Stanford University
Johns Hopkins University
University of Kansas Medical Center
Roswell Park Cancer Institute
Vanderbilt University Medical Center
M.D. Anderson Cancer Center
Fox Chase Cancer Center
Valerio Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)